Skip to content

Improving communication and patient safety in primary care for people aged 65+ with multiple long-term conditions

Improving communication and patient safety in multimorbidity: a feasibility study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13196605
Enrollment
80
Registered
2021-02-04
Start date
2020-12-31
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multimorbidity Not Applicable

Interventions

Description of the intervention as per the TIDieR (Template for Intervention Description and Replication) checklist for a protocol: Brief name: 1. SPEECH (Safer Patients Empowered to Engage and Commu

Sponsors

University of Manchester
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients aged 65+ with at least two long-term conditions Primary care staff: 1. Have direct contact with patients, that is, face-to-face and/or via telephone or the internet, and 2. Work in a clinical or administrative role. Clinical roles include GPs, practice nurses and practice pharmacists. Administrative roles include practice managers, and receptionists. All participants must have the capacity to provide informed consent, and be able to read and write in English to engage with study materials. This study does not have the scope to translate materials.

Exclusion criteria

Exclusion criteria: Patients: 1. Live in a care home or rely on a carer to manage their health 2. Have severe mental health problems, or significant cognitive impairment

Design outcomes

Primary

MeasureTime frame
Recruitment assessed using: 1. Number of general practices recruited and time taken to recruit, measured at baseline 2. Number of patients recruited and the number of expressions of interest as a proportion of the number of eligible patients invited to participate, measured at baseline

Secondary

MeasureTime frame
Delivery and data collection: 1. Feasibility of delivery assessed through in-depth interviews at 2 weeks after follow-up for patients and 2 weeks after the end of the study period for staff 2. Usability and acceptability of and engagement with the intervention measured using the patient and staff proformas (4- and 5-point Likert scales and free-text box) at 4-8-week follow-up for patients and at the end of the study period for staff, and through in-depth interviews at 2 weeks after follow-up for patients and 2 weeks after the end of the study period for staff 3. Number of questionnaires returned and the number of items completed per returned questionnaire, measured at baseline and 4-8-week follow-up for patients and at the end of the study period for staff

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 9, 2026